07/01/2025
8:50 PM | ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
06/25/2025
8:00 AM | ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/30/2025
3:15 PM | ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2025
2:09 PM | ARMISTICE CAPITAL, LLC (Filed by)
ZyVersa Therapeutics, Inc. (Subject)
ZyVersa Therapeutics, Inc. (Subject)
ZyVersa Therapeutics, Inc. (Subject)
ZyVersa Therapeutics (Subject)
ZyVersa Therapeutics, Inc. (Subject)
| Form SCHEDULE 13G | |
04/17/2025
3:32 PM | ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
| Form ARS | |
04/17/2025
3:30 PM | ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
| Form DEF 14A | |
04/17/2025
3:31 PM | ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
| Form DEFA14A | |
04/09/2025
11:15 PM | ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
| Form EFFECT | |
04/07/2025
4:26 PM | ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/07/2025
4:28 PM | ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
| Form PRE 14A | |
04/04/2025
3:46 PM | ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
Get the Latest News and Ratings for ZVSA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for ZyVersa Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
03/27/2025
8:05 AM | ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/07/2025
3:30 PM | ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/30/2024
7:30 AM | ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
| Form 424B3 | |
12/26/2024
11:15 PM | ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
| Form EFFECT | |
12/20/2024
4:04 PM | ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
12/20/2024
3:15 PM | ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
| Form PRE 14A | |
11/14/2024
5:01 PM | Anson Funds Management LP (Filed by)
ZyVersa Therapeutics, Inc. (Subject)
ZyVersa Therapeutics, Inc. (Subject)
ZyVersa Therapeutics, Inc. (Subject)
ZyVersa Therapeutics (Subject)
ZyVersa Therapeutics, Inc. (Subject)
| Form SC 13G/A | |
11/14/2024
7:30 AM | ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
7:00 AM | ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024
7:00 AM | ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2024
3:30 PM | ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/16/2024
4:29 PM | ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/16/2024
4:30 PM | ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
| Form 424B5 | |
09/10/2024
6:25 AM | ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
| Form 424B3 | |
09/10/2024
6:22 AM | ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
| Form 424B3 | |
09/09/2024
11:15 PM | ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
| Form EFFECT | |
09/09/2024
11:15 PM | ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
| Form EFFECT | |
09/09/2024
3:30 PM | ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
| Form DEF 14A | |
09/09/2024
3:32 PM | ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
| Form DEFA14A | |
09/09/2024
3:35 PM | ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
| Form ARS | |
09/03/2024
4:28 PM | ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
09/03/2024
4:29 PM | ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
08/30/2024
4:10 PM | ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
| Form PRE 14A | |
08/09/2024
3:30 PM | ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2024
7:00 AM | ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/18/2024
8:35 PM | Finizio Robert G (Reporting)
ZyVersa Therapeutics, Inc. (Issuer)
ZyVersa Therapeutics, Inc. (Issuer)
ZyVersa Therapeutics, Inc. (Issuer)
ZyVersa Therapeutics (Issuer)
ZyVersa Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2024
8:35 PM | SAPIRSTEIN JAMES (Reporting)
ZyVersa Therapeutics, Inc. (Issuer)
ZyVersa Therapeutics, Inc. (Issuer)
ZyVersa Therapeutics, Inc. (Issuer)
ZyVersa Therapeutics (Issuer)
ZyVersa Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2024
8:35 PM | Freitag Gregory Gene (Reporting)
ZyVersa Therapeutics, Inc. (Issuer)
ZyVersa Therapeutics, Inc. (Issuer)
ZyVersa Therapeutics, Inc. (Issuer)
ZyVersa Therapeutics (Issuer)
ZyVersa Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2024
8:35 PM | Park Min-Chul (Reporting)
ZyVersa Therapeutics, Inc. (Issuer)
ZyVersa Therapeutics, Inc. (Issuer)
ZyVersa Therapeutics, Inc. (Issuer)
ZyVersa Therapeutics (Issuer)
ZyVersa Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2024
8:35 PM | Glover Stephen C. (Reporting)
ZyVersa Therapeutics, Inc. (Issuer)
ZyVersa Therapeutics, Inc. (Issuer)
ZyVersa Therapeutics, Inc. (Issuer)
ZyVersa Therapeutics (Issuer)
ZyVersa Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
$100 Trillion “AI Metal” Found in American Ghost Town (Ad) Jeff Brown recently traveled to a ghost town in the middle of an American desert…
To investigate what could be the biggest technology story of this decade.
In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom…
And only one company here in the U.S. can mine this obscure metal. Click here to get the details on this virtual monopoly. |
07/18/2024
8:35 PM | Wolfe Peter (Reporting)
ZyVersa Therapeutics, Inc. (Issuer)
ZyVersa Therapeutics, Inc. (Issuer)
ZyVersa Therapeutics, Inc. (Issuer)
ZyVersa Therapeutics (Issuer)
ZyVersa Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2024
8:35 PM | Cashmere Karen A. (Reporting)
ZyVersa Therapeutics, Inc. (Issuer)
ZyVersa Therapeutics, Inc. (Issuer)
ZyVersa Therapeutics, Inc. (Issuer)
ZyVersa Therapeutics (Issuer)
ZyVersa Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2024
11:15 PM | ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
| Form EFFECT | |
07/11/2024
7:44 PM | ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics, Inc. (Filer)
ZyVersa Therapeutics (Filer)
ZyVersa Therapeutics, Inc. (Filer)
| Form POS AM | |
